Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings
about
Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adultsViral profiling identifies multiple subtypes of Kaposi's sarcoma.HHV-8 seroprevalence: a global viewIncidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort studyContribution of HIV infection to mortality among cancer patients in Uganda.Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.A review of the pattern of AIDS defining, HIV associated neoplasms and premalignant lesions diagnosed from 2000-2011 at Kenyatta National Hospital, KenyaRapid Multiplexed Immunoassay for Detection of Antibodies to Kaposi's Sarcoma-Associated HerpesvirusA prospective ascertainment of cancer incidence in sub-Saharan Africa: The case of Kaposi sarcomaHIV-1 Evolutionary Patterns Associated with Metastatic Kaposi's Sarcoma during AIDS.Comparison of Kaposi sarcoma risk in HIV-positive adults across five continents: a multiregional multicohort study.Diagnosis and Treatment of Kaposi Sarcoma.Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.Ultraviolet Radiation and Kaposi Sarcoma Incidence in a Nationwide US Cohort of HIV-Infected Men.A man with oral lesions, constipation and back pain.Incidence of Kaposi's sarcoma and associated mortality in Fresno, California, 1998 to 2012.KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite.
P2860
Q24193874-EA56814F-B9B1-4D04-A235-0BA60B917C6DQ34237734-F64D94EE-F6FF-4B7D-BDD6-371634B14163Q34403845-13F93849-0872-4AF5-9158-9D66DAB73C33Q34508985-BAB97CCE-0ED4-4F46-A9B7-95DE4BF7B73EQ35056551-8D0B7F67-5CD0-48F3-A874-F9C318C482D4Q35557475-50DCA3B2-FB9A-4A5C-BEFC-938730ADD8EBQ35754995-30515256-D63C-425D-92BF-51CA0EA991F6Q36145066-1DCB4B2F-60AA-44B3-AA36-E774B3BF73A6Q36895116-2327AB15-2428-4D84-9F1C-3EE7D836FD47Q37250125-FC31F2E1-F514-438D-93B7-9D985E7FAC5FQ38771101-241F695A-D85B-44DB-8757-C7C6C34FA68DQ39190555-5ABA7E8B-F67E-401A-A794-B7B3B58442C8Q40250347-D93DDA55-78B1-42D2-A455-9F502D5792D2Q40389262-DAD2956F-9854-468B-9B90-A55158C15329Q42236273-BE2CB7BE-6BA2-4BA3-9F4B-6226C571A09EQ45988560-43A17A97-8665-48CA-BBE4-67E8FA000B18Q50099317-D46736BB-15AA-40D0-B9A9-10392AB0F05C
P2860
Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Impact of antiretroviral thera ...... and resource-limited settings
@ast
Impact of antiretroviral thera ...... and resource-limited settings
@en
type
label
Impact of antiretroviral thera ...... and resource-limited settings
@ast
Impact of antiretroviral thera ...... and resource-limited settings
@en
prefLabel
Impact of antiretroviral thera ...... and resource-limited settings
@ast
Impact of antiretroviral thera ...... and resource-limited settings
@en
P2093
P2860
P1476
Impact of antiretroviral thera ...... and resource-limited settings
@en
P2093
Aggrey S Semeere
Jeffrey N Martin
Naftali Busakhala
P2860
P304
P356
10.1097/CCO.0B013E328355E14B
P577
2012-09-01T00:00:00Z